Dosing Optimization of Low-Sodium Oxybate in Narcolepsy and Idiopathic Hypersomnia in Adults: Consensus Recommendations

Abstract Introduction Low-sodium oxybate (LXB) is approved for treatment of narcolepsy in patients aged 7 years and older and treatment of idiopathic hypersomnia in adults. LXB contains the same active moiety with 92% less sodium than sodium oxybate (SXB). As the indication for oxybate treatment in...

Full description

Bibliographic Details
Published in:Neurology and Therapy
Main Authors: Anne Marie Morse, Richard K. Bogan, Asim Roy, Michael J. Thorpy
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-04-01
Subjects:
Consensus panel
Drug therapy
Idiopathic hypersomnia
Narcolepsy
Low-sodium oxybate
Recommendations
Online Access:https://doi.org/10.1007/s40120-024-00607-8

Internet

https://doi.org/10.1007/s40120-024-00607-8

Similar Items